Morteza Gholami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Morteza Gholami has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Farshad Sharifi
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran
7 shared publicationsMahsa M. Amoli
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular‐Cellular Sciences Institute Tehran University of Medical Sciences Tehran Iran
7 shared publications- Mahsa Mohammad Ammoli
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
6 shared publications - Kamyar Khoshnevisan
Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications - Ehsan Saboory
Zanjan Metabolic Diseases Research Center, Health and Metabolic Diseases Research Institute, Zanjan University of Medical Sciences, Zanjan, Iran.
3 shared publications - Shiva Roshan-Milani
Neurophysiology Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran
3 shared publications
Latest Publications
- 31 July 2026
- Published by Wiley in Psychogeriatrics
- Vol. 26 (5)
New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors
Introduction: This study aimed to explore shared genetic architectures underlying Alzheimer's disease (AD) and its known risk factors. Methods: Significant common variants between AD and its risk factors were identified using GWAS data. The 1000 Genomes Project genotyping data enabled the detection of linkage disequilibrium (LD) blocks and haplotype structures. Functional impact assessments, protein–protein interaction analyses, pathway mapping and enrichment studies were performed. Results: Sixteen significant variants across nine genes were associated with AD and at least one risk factor ( p ≤ 5 × 10 −8 ). Genes APOE, ABCA1 and TOMM40 showed strong associations with AD (adjusted p = 9.75 × 10 −9 ). High‐confidence interactions were identified among these genes, as well as APP and LRP1, within the AD pathway. Variant rs429358 ( p ≤ 3 × 10 −15 ) on the APOE gene was linked to AD, metabolic syndrome (MetS), diabetes, waist‐to‐hip ratio (WHR) and ageing. Variant rs2075650 ( p ≤ 6 × 10 −9 ) on TOMM40 correlated AD risk with MetS, WHR and body mass index (BMI). Variants rs483082 ( p ≤ 2 × 10 −32 ) and rs71352238 ( p ≤ 1 × 10 −11 ) on APOC1 and TOMM40 were associated with AD and MetS. Variants rs4420638 ( p ≤ 2 × 10 −34 ) and rs1800978 ( p ≤ 2 × 10 −9 ) on APOC1 and ABCA genes were associated with AD and WHR. The rs13237518 ( p ≤ 5 × 10 −11 ) was associated with AD risk in diabetic patients. Furthermore, the rs4277405 ( p ≤ 9 × 10 −20 ) associated AD with cardiovascular disease (CVD). Haplotypic structures were also identified for all these variants ( D ′ and r 2 ≥ 0.8). Discussion: This study identifies genetic variants and LD blocks on APOE, ABCA1, TOMM40 and APOC1 genes shared between AD and its risk factors, revealing common genetic links and potential shared susceptibility pathways.
- 31 July 2026
- Published by Wiley in Psychogeriatrics
- Vol. 26 (5)
New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors
Introduction: This study aimed to explore shared genetic architectures underlying Alzheimer's disease (AD) and its known risk factors. Methods: Significant common variants between AD and its risk factors were identified using GWAS data. The 1000 Genomes Project genotyping data enabled the detection of linkage disequilibrium (LD) blocks and haplotype structures. Functional impact assessments, protein–protein interaction analyses, pathway mapping and enrichment studies were performed. Results: Sixteen significant variants across nine genes were associated with AD and at least one risk factor ( p ≤ 5 × 10 −8 ). Genes APOE, ABCA1 and TOMM40 showed strong associations with AD (adjusted p = 9.75 × 10 −9 ). High‐confidence interactions were identified among these genes, as well as APP and LRP1, within the AD pathway. Variant rs429358 ( p ≤ 3 × 10 −15 ) on the APOE gene was linked to AD, metabolic syndrome (MetS), diabetes, waist‐to‐hip ratio (WHR) and ageing. Variant rs2075650 ( p ≤ 6 × 10 −9 ) on TOMM40 correlated AD risk with MetS, WHR and body mass index (BMI). Variants rs483082 ( p ≤ 2 × 10 −32 ) and rs71352238 ( p ≤ 1 × 10 −11 ) on APOC1 and TOMM40 were associated with AD and MetS. Variants rs4420638 ( p ≤ 2 × 10 −34 ) and rs1800978 ( p ≤ 2 × 10 −9 ) on APOC1 and ABCA genes were associated with AD and WHR. The rs13237518 ( p ≤ 5 × 10 −11 ) was associated with AD risk in diabetic patients. Furthermore, the rs4277405 ( p ≤ 9 × 10 −20 ) associated AD with cardiovascular disease (CVD). Haplotypic structures were also identified for all these variants ( D ′ and r 2 ≥ 0.8). Discussion: This study identifies genetic variants and LD blocks on APOE, ABCA1, TOMM40 and APOC1 genes shared between AD and its risk factors, revealing common genetic links and potential shared susceptibility pathways.
- Open Access
- 14 June 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (6) , e71554
Identification of Shared Genetic Variants and Haplotypes Associated With Schizophrenia and Depression
Introduction: Depression is highly prevalent among individuals with schizophrenia and significantly influences disease progression, treatment response, and risk of suicide. Despite its clinical relevance, the genetic underpinnings of depression comorbidity in schizophrenia remain poorly understood. This study aimed to identify shared genetic variants and haplotypic structures contributing to the susceptibility of both conditions. Methods: We systematically screened the GWAS catalog to identify genome‐wide significant variants shared between schizophrenia and depressive disorders. Linkage disequilibrium (LD) data from the 1000 Genomes Project were subsequently used to identify overlapping LD‐associated variants, followed by haplotype reconstruction using Phase 3 genotyping data. Finally, functional analyses including brain expression quantitative trait loci (eQTL) mapping and protein–protein interaction (PPI) network analysis of genes associated with the identified variants were performed to explore their potential biological relevance. Results: Twelve shared GWAS variants were identified ( p < 5×10 − 6 ), among which two haplotype blocks were associated with an increased risk of both disorders, including the GTCG haplotype containing rs589249 and the GG haplotype containing rs10767735. These were integrated into a novel composite structure (GTCG–GG), which may serve as a predictive marker for the co‐occurrence of schizophrenia and depression. Additionally, rs13218591 (on BTN3A1) and rs75782365 (on BTN3A2) emerged as key shared variants (SNP p < 5×10 − 8 , PPI = 0.99). Conclusion: These findings highlight potential genetic markers that may contribute to the overlapping etiology of schizophrenia and depression. The identified haplotypic structures offer promising candidates for future diagnostic panels and provide a basis for further investigating of the genetic mechanisms underlying comorbidity in psychiatric disorders.
- 14 June 2026
- Published by Wiley in Brain and Behavior
- Vol. 16 (6) , e71554
Open AccessIdentification of Shared Genetic Variants and Haplotypes Associated With Schizophrenia and Depression
Introduction: Depression is highly prevalent among individuals with schizophrenia and significantly influences disease progression, treatment response, and risk of suicide. Despite its clinical relevance, the genetic underpinnings of depression comorbidity in schizophrenia remain poorly understood. This study aimed to identify shared genetic variants and haplotypic structures contributing to the susceptibility of both conditions. Methods: We systematically screened the GWAS catalog to identify genome‐wide significant variants shared between schizophrenia and depressive disorders. Linkage disequilibrium (LD) data from the 1000 Genomes Project were subsequently used to identify overlapping LD‐associated variants, followed by haplotype reconstruction using Phase 3 genotyping data. Finally, functional analyses including brain expression quantitative trait loci (eQTL) mapping and protein–protein interaction (PPI) network analysis of genes associated with the identified variants were performed to explore their potential biological relevance. Results: Twelve shared GWAS variants were identified ( p < 5×10 − 6 ), among which two haplotype blocks were associated with an increased risk of both disorders, including the GTCG haplotype containing rs589249 and the GG haplotype containing rs10767735. These were integrated into a novel composite structure (GTCG–GG), which may serve as a predictive marker for the co‐occurrence of schizophrenia and depression. Additionally, rs13218591 (on BTN3A1) and rs75782365 (on BTN3A2) emerged as key shared variants (SNP p < 5×10 − 8 , PPI = 0.99). Conclusion: These findings highlight potential genetic markers that may contribute to the overlapping etiology of schizophrenia and depression. The identified haplotypic structures offer promising candidates for future diagnostic panels and provide a basis for further investigating of the genetic mechanisms underlying comorbidity in psychiatric disorders.
- Open Access
- 5 December 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (12) , e70228
Genetic Variants and Haplotype Structures in the CASC Gene Family to Predict Cancer Risk: A Bioinformatics Study
Background and Aims: The cancer susceptibility (CASC) gene family of long noncoding RNAs (lncRNAs) plays an important role in cancer. The aim of this study was to identify genetic variants and haplotype structures of CASC genes associated with cancer risk.Methods: Genome‐wide association studies (GWAS) significant variants (p ≤ 5 × 10−8) on CASC family genes were identified from the GWAS Catalog‐EMBL‐EBI, and then cancer‐associated variants on CASC genes were extracted. These variants were functionally analyzed, including lncRNA:miRNA binding sites, Regulomedb scores, and eQTL. The 1000 Genome Project genotyping data Phase III were used to identify haplotypic blocks. Finally, the genes associated with them were examined for expression and gene‐gene correlation analyses using OncoDB.Results: There were six haplotypic blocks in four genes. The GC, TA, and AGAC haplotypes are located in the CASC8 gene and increase the risk of prostate cancer, breast cancer, and colorectal cancer, respectively. The CA haplotype in the CASC15 gene increases the risk of neuroblastoma, AA haplotype in the CASC16 gene increases the risk of breast cancer, and ACGATG haplotype in the CASC17 gene increases the risk of prostate cancer (p ≤ 5 × 10−8). Their genes are interrelated and their expression is increased in these cancers. The rs2294214 is associated with skin cancer and has positive effects on five CASC15:miRNA binding sites. The rs3803662 is located in CASC16:miRNA binding sites, which has positive effects on hsa‐miR‐4475 and hsa‐miR‐7845‐5p and negative effects on hsa‐miR‐4524a‐3p and hsa‐miR‐4524b‐3p.Conclusion: These haplotypic structures and lncRNA:miRNA:SNP interactions on CASC family lncRNAs reveal novel genetic associations between CASC genes and various cancers.
- 5 December 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (12) , e70228
Open AccessGenetic Variants and Haplotype Structures in the CASC Gene Family to Predict Cancer Risk: A Bioinformatics Study
Background and Aims: The cancer susceptibility (CASC) gene family of long noncoding RNAs (lncRNAs) plays an important role in cancer. The aim of this study was to identify genetic variants and haplotype structures of CASC genes associated with cancer risk.Methods: Genome‐wide association studies (GWAS) significant variants (p ≤ 5 × 10−8) on CASC family genes were identified from the GWAS Catalog‐EMBL‐EBI, and then cancer‐associated variants on CASC genes were extracted. These variants were functionally analyzed, including lncRNA:miRNA binding sites, Regulomedb scores, and eQTL. The 1000 Genome Project genotyping data Phase III were used to identify haplotypic blocks. Finally, the genes associated with them were examined for expression and gene‐gene correlation analyses using OncoDB.Results: There were six haplotypic blocks in four genes. The GC, TA, and AGAC haplotypes are located in the CASC8 gene and increase the risk of prostate cancer, breast cancer, and colorectal cancer, respectively. The CA haplotype in the CASC15 gene increases the risk of neuroblastoma, AA haplotype in the CASC16 gene increases the risk of breast cancer, and ACGATG haplotype in the CASC17 gene increases the risk of prostate cancer (p ≤ 5 × 10−8). Their genes are interrelated and their expression is increased in these cancers. The rs2294214 is associated with skin cancer and has positive effects on five CASC15:miRNA binding sites. The rs3803662 is located in CASC16:miRNA binding sites, which has positive effects on hsa‐miR‐4475 and hsa‐miR‐7845‐5p and negative effects on hsa‐miR‐4524a‐3p and hsa‐miR‐4524b‐3p.Conclusion: These haplotypic structures and lncRNA:miRNA:SNP interactions on CASC family lncRNAs reveal novel genetic associations between CASC genes and various cancers.
- 28 August 2024
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 31 (7) , 1086-1093
Novel genetic structures associated with adverse response to chemotherapy in breast cancer
Introduction: The role of genetic variants in response to chemotherapy has been investigated in several studies. This study aimed to investigate genetic variants associated with response to chemotherapy in breast cancer (BC) patients. Methods: Significant variants (p < 5 × 10 −8 ) associated with response to chemotherapy were obtained from GWA studies. Candidate variants were identified by haplotype analysis (r2 ≥ 0.9, D′≥0.9) using 1000Genome LD data. To determine the effects of the variants on gene expression, expression quantitative trait loci (eQTL) were evaluated. To compare the expression of the identified genes in tumor samples, expression levels were compared between TCGA tumor types and adjacent normal tissues. Results: Six rs3820706, rs147451859, rs4784750, rs17587029, rs16830728, and rs16972207 variants were significantly associated with response to chemotherapy in BC patients (p < 5 × 10 −8 ). Seven novel haplotypic structures were identified to be associated with adverse response to chemotherapy in BC patients. These haplotypes formed two genetic structures associated with neutropenia, leukopenia, chemotherapy-induced cytotoxicity (GAG-TTAT), and chemotherapy-induced alopecia (CC-CAACTCCCGTTGCGG). These variants are located on PPCDC, NLRC5, STAM2, and TNFSF13B genes, and the expression of these genes significantly changed in BC tissues than normal tissues (P ≤ 0.05), also showing gene-gene correlation (P ≤ 0.05). Conclusions: These genetic variants and their associated novel haplotypic structures can predict adverse response to chemotherapy in BC patients and could potentially form BC-associated genetic panel for adverse response to chemotherapy.
- 28 August 2024
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 31 (7) , 1086-1093
Novel genetic structures associated with adverse response to chemotherapy in breast cancer
Introduction: The role of genetic variants in response to chemotherapy has been investigated in several studies. This study aimed to investigate genetic variants associated with response to chemotherapy in breast cancer (BC) patients. Methods: Significant variants (p < 5 × 10 −8 ) associated with response to chemotherapy were obtained from GWA studies. Candidate variants were identified by haplotype analysis (r2 ≥ 0.9, D′≥0.9) using 1000Genome LD data. To determine the effects of the variants on gene expression, expression quantitative trait loci (eQTL) were evaluated. To compare the expression of the identified genes in tumor samples, expression levels were compared between TCGA tumor types and adjacent normal tissues. Results: Six rs3820706, rs147451859, rs4784750, rs17587029, rs16830728, and rs16972207 variants were significantly associated with response to chemotherapy in BC patients (p < 5 × 10 −8 ). Seven novel haplotypic structures were identified to be associated with adverse response to chemotherapy in BC patients. These haplotypes formed two genetic structures associated with neutropenia, leukopenia, chemotherapy-induced cytotoxicity (GAG-TTAT), and chemotherapy-induced alopecia (CC-CAACTCCCGTTGCGG). These variants are located on PPCDC, NLRC5, STAM2, and TNFSF13B genes, and the expression of these genes significantly changed in BC tissues than normal tissues (P ≤ 0.05), also showing gene-gene correlation (P ≤ 0.05). Conclusions: These genetic variants and their associated novel haplotypic structures can predict adverse response to chemotherapy in BC patients and could potentially form BC-associated genetic panel for adverse response to chemotherapy.
- Open Access
- 21 June 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (6) , e2107
Common and novel haplotype structures between different types of cancer
Background: Background: Genome‐wide association studies (GWAS) have identified hundreds of genetic variants associated with cancer risk. GWAS data are important for cancer prevention and understanding the underlying mechanisms of cancer.Aims: This study aimed to investigate the genetic association between different types of cancer using GWAS data and a bioinformatics approach.Methods and results: The significant GWAS variants associated with more than one cancer type were identified. Common linkage disequilibrium (LD) variants between different types of cancer were identified by 1000 genomes phase 3 LD data. Haplotype blocks were identified by analyzing 1000 Genomes phase 3 genotyping data in the GWAS populations. Subsequent analyses included functional SNP analyses and TCGA gene expression. The results associated with significant GWAS variants (P<5E‐8) showed the following haplotype associations in European population: GT rs4808075‐rs8170 haplotype on BABAM1 with breast and ovarian cancers, GC rs16857609‐rs11693806 haplotype on DIRC3 with breast and thyroid cancers, GCG rs380286‐rs401681‐rs31487 haplotype on CLPTM1L with skin and lung cancers, GGG rs4430796‐rs11651052‐rs11263763 haplotype on HNF1B with prostate and endometrial cancers, and GT rs10505477‐rs6983267 haplotype on CASC8 associated with colorectal and prostate cancers. All these genes had significantly different expressions in tumor tissues (P<1E‐3). In addition, the rs11693806 variant is located in the hsa‐miR‐873‐5p binding site and has an enhancing effect on the hsa‐miR‐873‐5p:DIRC3 interaction.Conclusion: These novel haplotype structures and miRNA:lncRNA interactions are important for understanding the common genetic link between cancers. These results can potentially be used in genetic panels.
- 21 June 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (6) , e2107
Open AccessCommon and novel haplotype structures between different types of cancer
Background: Background: Genome‐wide association studies (GWAS) have identified hundreds of genetic variants associated with cancer risk. GWAS data are important for cancer prevention and understanding the underlying mechanisms of cancer.Aims: This study aimed to investigate the genetic association between different types of cancer using GWAS data and a bioinformatics approach.Methods and results: The significant GWAS variants associated with more than one cancer type were identified. Common linkage disequilibrium (LD) variants between different types of cancer were identified by 1000 genomes phase 3 LD data. Haplotype blocks were identified by analyzing 1000 Genomes phase 3 genotyping data in the GWAS populations. Subsequent analyses included functional SNP analyses and TCGA gene expression. The results associated with significant GWAS variants (P<5E‐8) showed the following haplotype associations in European population: GT rs4808075‐rs8170 haplotype on BABAM1 with breast and ovarian cancers, GC rs16857609‐rs11693806 haplotype on DIRC3 with breast and thyroid cancers, GCG rs380286‐rs401681‐rs31487 haplotype on CLPTM1L with skin and lung cancers, GGG rs4430796‐rs11651052‐rs11263763 haplotype on HNF1B with prostate and endometrial cancers, and GT rs10505477‐rs6983267 haplotype on CASC8 associated with colorectal and prostate cancers. All these genes had significantly different expressions in tumor tissues (P<1E‐3). In addition, the rs11693806 variant is located in the hsa‐miR‐873‐5p binding site and has an enhancing effect on the hsa‐miR‐873‐5p:DIRC3 interaction.Conclusion: These novel haplotype structures and miRNA:lncRNA interactions are important for understanding the common genetic link between cancers. These results can potentially be used in genetic panels.
- 4 January 2024
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (7) , 3645-3651
Genetic variants and haplotype structures of miRNA host genes in cancer and obesity
Cancer and obesity are two important public health problems. This study aimed to investigate the role of genetic variants and haplotypes of miRNA host genes in cancer and obesity. Data from the catalog of genome-wide association studies (GWAS) were used to find significant variants (index). Then, 1000-genome phase 3 data were used to find haplotypic variants (proxy) associated with these diseases. The candidate variants and haplotypes were identified from proxy and index variants. Finally, SNP function analysis was performed. All GWAS-significant cancer-associated miRNA host gene variants, including MIR4713HG, MIR663AHG, MIR99AHG and MIR4435-2HG, were also significantly associated with obesity. The rs703764 variant was common between cutaneous melanoma and obesity traits in the European population (P ≤ 5E-8). The rs2414098 variant was associated with endometrial cancer (P ≤ 5E-13), and the rs7173595 variant was associated with waist-hip ratio (P ≤ 5E-13) and new CGGCATCA haplotypic located at MIR4713HG was identified in the European population. In addition, the ATCTTGTT haplotype for rs17041868 in MIR4435-2HG was identified to be associated with obesity traits (waist-hip ratio and BMI) in the European population (P ≤ 5E-8). This study found that rs703764 is a common genetic marker between cancer and obesity. The CGGCATCA haplotype is common between endometrial cancer and waist-hip ratio. Also, ATCTTGTT haplotype is associated with obesity traits. These results indicate that the variants and haplotypes of miRNAs host genes play an important role between cancer and obesity in the European population. It is suggested to investigate the effect of these structures in other populations.Communicated by Ramaswamy H. Sarma.
- 4 January 2024
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (7) , 3645-3651
Genetic variants and haplotype structures of miRNA host genes in cancer and obesity
Cancer and obesity are two important public health problems. This study aimed to investigate the role of genetic variants and haplotypes of miRNA host genes in cancer and obesity. Data from the catalog of genome-wide association studies (GWAS) were used to find significant variants (index). Then, 1000-genome phase 3 data were used to find haplotypic variants (proxy) associated with these diseases. The candidate variants and haplotypes were identified from proxy and index variants. Finally, SNP function analysis was performed. All GWAS-significant cancer-associated miRNA host gene variants, including MIR4713HG, MIR663AHG, MIR99AHG and MIR4435-2HG, were also significantly associated with obesity. The rs703764 variant was common between cutaneous melanoma and obesity traits in the European population (P ≤ 5E-8). The rs2414098 variant was associated with endometrial cancer (P ≤ 5E-13), and the rs7173595 variant was associated with waist-hip ratio (P ≤ 5E-13) and new CGGCATCA haplotypic located at MIR4713HG was identified in the European population. In addition, the ATCTTGTT haplotype for rs17041868 in MIR4435-2HG was identified to be associated with obesity traits (waist-hip ratio and BMI) in the European population (P ≤ 5E-8). This study found that rs703764 is a common genetic marker between cancer and obesity. The CGGCATCA haplotype is common between endometrial cancer and waist-hip ratio. Also, ATCTTGTT haplotype is associated with obesity traits. These results indicate that the variants and haplotypes of miRNAs host genes play an important role between cancer and obesity in the European population. It is suggested to investigate the effect of these structures in other populations.Communicated by Ramaswamy H. Sarma.
- 9 December 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 204 (1) , 159-169
FTO is a major genetic link between breast cancer, obesity, and diabetes
Purpose Breast cancer (BC), obesity, and type 2 diabetes mellitus (T2DM) are three complex diseases and health problems that are prevalent worldwide. The aim of this study was to investigate the common genetic associations between these diseases by referring back to the previous genome-wide association studies (GWAS). Methods To this end, significant GWAS variants and common variants associated with BC, obesity, or diabetes were identified from the GWAS catalog. To perform candidate variants, the 1000-Genomes Project was used to find variants with linkage disequilibrium. Common variants between each category were identified (common candidate haplotypic variants). Finally, these variants and their associated genes were examined for SNP function analysis, gene expression, gene–gene correlation, and pathway analysis. Results The results identified 7 variants associated with both T2DM and BC, 8 variants associated with both obesity and BC, and 167 variants associating obesity with T2DM. 91 variants and 4 haplotypic blocks such as CTC were identified on the FTO gene associated with obesity, BC, and T2DM. The results of TCGA data showed that FTO in gene expression was correlated with 6 other genes in the DNA repair pathway in BC subjects. Conclusions This study suggests that the FTO gene is one of the major genes shared by BC, T2DM, and obesity based on two DNA repair and inflammatory mechanisms. These results may provide a new perspective on the important role of the FTO gene and repair mechanism in the relationship between BC, obesity, and T2DM for future studies.
- 9 December 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 204 (1) , 159-169
FTO is a major genetic link between breast cancer, obesity, and diabetes
Purpose Breast cancer (BC), obesity, and type 2 diabetes mellitus (T2DM) are three complex diseases and health problems that are prevalent worldwide. The aim of this study was to investigate the common genetic associations between these diseases by referring back to the previous genome-wide association studies (GWAS). Methods To this end, significant GWAS variants and common variants associated with BC, obesity, or diabetes were identified from the GWAS catalog. To perform candidate variants, the 1000-Genomes Project was used to find variants with linkage disequilibrium. Common variants between each category were identified (common candidate haplotypic variants). Finally, these variants and their associated genes were examined for SNP function analysis, gene expression, gene–gene correlation, and pathway analysis. Results The results identified 7 variants associated with both T2DM and BC, 8 variants associated with both obesity and BC, and 167 variants associating obesity with T2DM. 91 variants and 4 haplotypic blocks such as CTC were identified on the FTO gene associated with obesity, BC, and T2DM. The results of TCGA data showed that FTO in gene expression was correlated with 6 other genes in the DNA repair pathway in BC subjects. Conclusions This study suggests that the FTO gene is one of the major genes shared by BC, T2DM, and obesity based on two DNA repair and inflammatory mechanisms. These results may provide a new perspective on the important role of the FTO gene and repair mechanism in the relationship between BC, obesity, and T2DM for future studies.
- 20 November 2023
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 23 (1) , 739-744
Novel genetic association between obesity, colorectal cancer, and inflammatory bowel disease
Purpose Obesity/overweight is an important risk factor for CRC and IBD. The aim of this study was to investigate the role of common genetic factors and haplotypes associated with obesity, CRC and IBD. Methods Significant GWAS variants associated with CRC, IBD or obesity were extracted from the GWAS catalog. The common variants between CRC-IBD, CRC-obesity or IBD-obesity were identified. Finally, the haplotypic structure between these diseases was identified, and SNP function analysis, gene-gene expression, protein-protein interactions, gene survival analysis and pathway analysis were performed with the results. Results While the results showed several common variants between CRC and IBD, IBD and obesity, and CRC and obesity identified in previous GWAS, rs3184504 was the only common variant for CRC-IBD-obesity (P ≤ 5E-8). The result also identified a haplotypic block AGCAGT (r2 ≥ 0.8 and D’≥0.08) associated with the common variants of CRC-IBD-obesity. These variants are located on the SH2B3 gene, whose expression level decreases in both colon and rectal cancers (P ≤ 1E-3) and which has protein-protein interaction with inflammation- and cancer-associated genes. Conclusion The rs3184504 variant and the novel haplotype AGCAGT co-occurred in CRC, IBD, obesity, and inflammation. This novel haplotype could potentially be used in genetic panels to identify CRC/IBD susceptibility in obese patients.
- 20 November 2023
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 23 (1) , 739-744
Novel genetic association between obesity, colorectal cancer, and inflammatory bowel disease
Purpose Obesity/overweight is an important risk factor for CRC and IBD. The aim of this study was to investigate the role of common genetic factors and haplotypes associated with obesity, CRC and IBD. Methods Significant GWAS variants associated with CRC, IBD or obesity were extracted from the GWAS catalog. The common variants between CRC-IBD, CRC-obesity or IBD-obesity were identified. Finally, the haplotypic structure between these diseases was identified, and SNP function analysis, gene-gene expression, protein-protein interactions, gene survival analysis and pathway analysis were performed with the results. Results While the results showed several common variants between CRC and IBD, IBD and obesity, and CRC and obesity identified in previous GWAS, rs3184504 was the only common variant for CRC-IBD-obesity (P ≤ 5E-8). The result also identified a haplotypic block AGCAGT (r2 ≥ 0.8 and D’≥0.08) associated with the common variants of CRC-IBD-obesity. These variants are located on the SH2B3 gene, whose expression level decreases in both colon and rectal cancers (P ≤ 1E-3) and which has protein-protein interaction with inflammation- and cancer-associated genes. Conclusion The rs3184504 variant and the novel haplotype AGCAGT co-occurred in CRC, IBD, obesity, and inflammation. This novel haplotype could potentially be used in genetic panels to identify CRC/IBD susceptibility in obese patients.
- 9 October 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (12) , 5245-5257
A systematic review and meta-analysis of the global epidemiology of pediatric traumatic spinal cord injuries
Despite being relatively rare, pediatric traumatic spinal cord injury (TSCI) is a debilitating event with high morbidity and long-term damage and dependency. This study aims to provide insight on the epidemiological characteristics of pediatric TSCI worldwide. The studies were included if they provided data for the pediatric population with the diagnosis of TSCI. Information sources included PubMed, Embase, Web of Science, and Scopus. All databases were searched from 1990 to April 2023. The quality of included studies was evaluated by Joanna Briggs Institute Critical Appraisal Tools. The results of the meta-analysis were presented as forest plots. PROSPERO Registration code: CRD42020189757. We identified 87 studies from 18 developed and 11 developing countries. Of the 87 studies evaluated, 52 studies were considered medium quality, 27 studies were considered high quality, and 8 studies were considered low quality. In developed countries, the proportion of TSCIs occurring in patients aged 0–15 years was 3% (95% CI: 2.2%; 3.9%), while in developing countries, it was 4.5% (95% CI: 2.8%; 6.4%). In developed countries, the pooled incidence of pediatric TSCI was 4.3/millions of children aged 0–15/year (95% CI: 3.1; 6.0/millions children aged 0–15/year) and boys comprised 67% (95% CI: 63%; 70%) of cases. The most prevalent level of injury was cervical (50% [95% CI: 41%; 58%]). The frequency of SCI Without Obvious Radiological Abnormality (SCIWORA) was 35% (95% CI: 18%; 54%) among children 0–17 years. The most common etiology in developed countries was transport injuries (50% [95% CI: 42%; 57%]), while in developing countries falls were the leading cause (31% [95% CI: 20%; 42%]). The most important limitation of our study was the heterogeneity of studies in reporting age subgroups that hindered us from age-specific analyses. Conclusion: Our study provided accurate estimates for the epidemiology of pediatric TSCI. We observed a higher proportion of pediatric TSCI cases in developing countries compared to developed countries. Furthermore, we identified distinct epidemiological characteristics of pediatric TSCI when compared to adult cases and variations between developing and developed countries. Recognizing these unique features allows for the implementation of cost-effective preventive strategies aimed at reducing the incidence and burden of TSCI in children. What is Known: • Pediatric Traumatic Spinal Cord Injury (TSCI) can have profound physical and social consequences for affected children, their families, and society as a whole. • Epidemiological insights are vital for they provide the data and understanding needed to the identification of vulnerable populations, aiding in the development of targeted prevention strategies and effective resource allocation. What is New: • The estimated incidence of pediatric TSCI in developed countries is 4.3 cases per million children aged 0-15. The proportion of pediatric TSCI cases in relation to all-age TSCI cases is 3% in developed countries and 4.5% in developing countries. • The etiology of TSCI in pediatric cases differs between developing and developed countries. In developed countries, transport injuries are the most prevalent cause of pediatric TSCI, while falls are the least common cause. Conversely, in developing countries, falls are the leading cause of pediatric TSCI.
- 9 October 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (12) , 5245-5257
A systematic review and meta-analysis of the global epidemiology of pediatric traumatic spinal cord injuries
Despite being relatively rare, pediatric traumatic spinal cord injury (TSCI) is a debilitating event with high morbidity and long-term damage and dependency. This study aims to provide insight on the epidemiological characteristics of pediatric TSCI worldwide. The studies were included if they provided data for the pediatric population with the diagnosis of TSCI. Information sources included PubMed, Embase, Web of Science, and Scopus. All databases were searched from 1990 to April 2023. The quality of included studies was evaluated by Joanna Briggs Institute Critical Appraisal Tools. The results of the meta-analysis were presented as forest plots. PROSPERO Registration code: CRD42020189757. We identified 87 studies from 18 developed and 11 developing countries. Of the 87 studies evaluated, 52 studies were considered medium quality, 27 studies were considered high quality, and 8 studies were considered low quality. In developed countries, the proportion of TSCIs occurring in patients aged 0–15 years was 3% (95% CI: 2.2%; 3.9%), while in developing countries, it was 4.5% (95% CI: 2.8%; 6.4%). In developed countries, the pooled incidence of pediatric TSCI was 4.3/millions of children aged 0–15/year (95% CI: 3.1; 6.0/millions children aged 0–15/year) and boys comprised 67% (95% CI: 63%; 70%) of cases. The most prevalent level of injury was cervical (50% [95% CI: 41%; 58%]). The frequency of SCI Without Obvious Radiological Abnormality (SCIWORA) was 35% (95% CI: 18%; 54%) among children 0–17 years. The most common etiology in developed countries was transport injuries (50% [95% CI: 42%; 57%]), while in developing countries falls were the leading cause (31% [95% CI: 20%; 42%]). The most important limitation of our study was the heterogeneity of studies in reporting age subgroups that hindered us from age-specific analyses. Conclusion: Our study provided accurate estimates for the epidemiology of pediatric TSCI. We observed a higher proportion of pediatric TSCI cases in developing countries compared to developed countries. Furthermore, we identified distinct epidemiological characteristics of pediatric TSCI when compared to adult cases and variations between developing and developed countries. Recognizing these unique features allows for the implementation of cost-effective preventive strategies aimed at reducing the incidence and burden of TSCI in children. What is Known: • Pediatric Traumatic Spinal Cord Injury (TSCI) can have profound physical and social consequences for affected children, their families, and society as a whole. • Epidemiological insights are vital for they provide the data and understanding needed to the identification of vulnerable populations, aiding in the development of targeted prevention strategies and effective resource allocation. What is New: • The estimated incidence of pediatric TSCI in developed countries is 4.3 cases per million children aged 0-15. The proportion of pediatric TSCI cases in relation to all-age TSCI cases is 3% in developed countries and 4.5% in developing countries. • The etiology of TSCI in pediatric cases differs between developing and developed countries. In developed countries, transport injuries are the most prevalent cause of pediatric TSCI, while falls are the least common cause. Conversely, in developing countries, falls are the leading cause of pediatric TSCI.
- 1 June 2022
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 132 (6) , 4186-4207
Interactive relationship between Trp metabolites and gut microbiota: The impact on human pathology of disease
Tryptophan (Trp), an α-amino acid, is the precursor of serotonin (5-hydroxytryptamine, 5-HT), which is involved in a variety of features of metabolic function and human nutrition. Evidence highlights the role of Trp metabolites (exclusively 5-HT) in the gastrointestinal (GI) tract; however, the mechanisms of action involved in the release of 5-HT in the GI tract are still unknown. Considering the fact that variations of 5-HT may facilitate the growth of certain GI disorders, gaining a better understanding of the function and release of 5-HT in the GI tract would be beneficial. Additionally, investigating Trp metabolism may clarify the relationship between Trp and gut microbiota. It is believed that other metabolites of Trp (mostly that of the kynurenine pathway) may play a significant role in controlling gut microbiota function. In this review, we have attempted to summarize the current research investigating the relationship of gut microbiota, Trp and 5-HT metabolism (with particular attention paid to their metabolite type, as well as a discussion of the research methods used in each study). Taking together, regarding the role that Trp/5-HT plays in a range of physical and mental diseases, the gut bacterial types, as well as the related disorders, have been exclusively considered.
- 1 June 2022
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 132 (6) , 4186-4207
Interactive relationship between Trp metabolites and gut microbiota: The impact on human pathology of disease
Tryptophan (Trp), an α-amino acid, is the precursor of serotonin (5-hydroxytryptamine, 5-HT), which is involved in a variety of features of metabolic function and human nutrition. Evidence highlights the role of Trp metabolites (exclusively 5-HT) in the gastrointestinal (GI) tract; however, the mechanisms of action involved in the release of 5-HT in the GI tract are still unknown. Considering the fact that variations of 5-HT may facilitate the growth of certain GI disorders, gaining a better understanding of the function and release of 5-HT in the GI tract would be beneficial. Additionally, investigating Trp metabolism may clarify the relationship between Trp and gut microbiota. It is believed that other metabolites of Trp (mostly that of the kynurenine pathway) may play a significant role in controlling gut microbiota function. In this review, we have attempted to summarize the current research investigating the relationship of gut microbiota, Trp and 5-HT metabolism (with particular attention paid to their metabolite type, as well as a discussion of the research methods used in each study). Taking together, regarding the role that Trp/5-HT plays in a range of physical and mental diseases, the gut bacterial types, as well as the related disorders, have been exclusively considered.